Form 4: Centene CEO Sarah London Buys CNC Stock

Centene CEO Sarah London acquired 19,230 shares of common stock at an average price of $25.50, increasing her direct beneficial ownership.

Summary

• Centene CEO and Director Sarah London purchased 19,230 shares of Centene Corp (CNC) common stock.
• The acquisition occurred on August 8, 2025, at a weighted average price of $25.50 per share, with prices ranging from $25.49 to $25.50.
• This transaction was executed pursuant to a Rule 10b5-1(c) pre-planned contract.
• Following the purchase, Sarah London directly beneficially owns 845,275 shares of common stock.
• Her total ownership includes 591,998 shares of previously-granted restricted stock units and performance stock units, which are subject to vesting requirements.
• Sarah London also holds 13,449 Common Stock Options with an exercise price of $81.85, granted on December 15, 2021.
• These options may become exercisable on or after the third anniversary of the grant date if CNC's common stock closing price equals or exceeds $100 per share for 20 consecutive trading days.

Sentiment

Score: 8

Explanation: The purchase of company stock by the CEO is a strong positive signal, indicating high confidence in the company's future prospects and aligning management's interests with shareholders. The pre-planned nature of the transaction further reinforces this positive sentiment.

Positives

• The Chief Executive Officer and Director, Sarah London, purchased shares, indicating strong confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned investment strategy rather than a reactive one.

Future Outlook

The filing indicates a performance stock option that may become exercisable if Centene's common stock equals or exceeds $100 per share for 20 consecutive trading days following the third anniversary of the December 15, 2021 grant date, suggesting a long-term performance target and management's belief in significant future stock appreciation.

Industry Context

Centene Corp operates in the healthcare and managed care industry. An insider purchase by the CEO could signal internal confidence in the company's strategy and future performance within this sector, potentially reflecting expectations for favorable regulatory environments or successful execution of business plans.

Comparison to Industry Standards

• Insider purchases, especially by a CEO, are generally viewed positively across industries as they align management's interests with shareholders.
• While specific comparable companies or projects are not detailed in this filing, a CEO buying shares at $25.50, while also holding options with an $81.85 strike price and a $100 performance target, suggests a belief in significant future stock appreciation, which is a strong signal compared to typical market sentiment.

Related Party Transactions

• The filing discloses an insider transaction where the Chief Executive Officer and Director, Sarah London, purchased 19,230 shares of the company's common stock.

Stakeholder Impact

• Shareholders: The CEO's purchase of shares can be seen as a positive signal, potentially increasing investor confidence and aligning management's interests with shareholders.
• Employees: May view the CEO's investment as a sign of stability and belief in the company's long-term success.

Next Steps

• The performance stock option may become exercisable on or after December 15, 2024 (third anniversary of grant date) if the stock price condition of $100 for 20 consecutive trading days is met.

Key Dates

Recommendation

The CEO's direct purchase of a significant number of shares at $25.50, coupled with holding options with a much higher strike price and performance target ($100), signals strong conviction in the company's future growth and valuation. This insider buying activity, especially from the top executive, is a powerful indicator of management's belief that the stock is undervalued and has substantial upside potential. The pre-planned nature of the transaction (10b5-1 plan) suggests a deliberate, long-term investment strategy.

Keywords

Centene Corp, CNC, Sarah London, Insider Trading, Stock Purchase, CEO, Form 4, Equity Acquisition, Healthcare, Managed Care